Spiro George Rombotis, President & CEO, Director at Cyclacel Pharmaceuticals, holds 68.66K shares in Cyclacel Pharmaceuticals (Ticker: CYCC). Most recently, Spiro George Rombotis Bought $6,070 shares of Cyclacel Pharmaceuticals on Dec 26, 2023 for an estimated value of 20.09K.